scholarly journals Single‐ and multiple‐dose pharmacokinetics and safety of pimodivir, a novel, non‐nucleoside polymerase basic protein 2 subunit inhibitor of the influenza A virus polymerase complex, and interaction with oseltamivir: a Phase 1 open‐label study in healthy volunteers

2018 ◽  
Vol 84 (11) ◽  
pp. 2663-2672 ◽  
Author(s):  
Sofie Deleu ◽  
Thomas N. Kakuda ◽  
Kurt Spittaels ◽  
Jurgen J. Vercauteren ◽  
Vera Hillewaert ◽  
...  
Keyword(s):  
Healthy Volunteers ◽  
Influenza A Virus ◽  
Influenza A ◽  
Multiple Dose ◽  
Basic Protein ◽  
Phase 1 ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Multiple Dose Pharmacokinetics

Phase 1 open-label study evaluating the safety, pharmacokinetics, and preliminary efficacy of dilpacimab in patients with advanced solid tumors

2021 ◽  
pp. molcanther.0985.2020
Author(s):  
Michael S. Gordon ◽  
John Nemunaitis ◽  
Minal Barve ◽  
Zev A. Wainberg ◽  
Erika P. Hamilton ◽  
...  
Keyword(s):  
Solid Tumors ◽  
Phase 1 ◽  
Advanced Solid Tumors ◽  
Open Label ◽  
Open Label Study ◽  
Label Study
Sign in / Sign up

Export Citation Format

Share Document